Omega-3 Fatty Acids: Evidence Basis for Treatment and Future Research in Psychiatry
The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Objective To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders. Participants The authors of this article were invited participants in the Omega-3 Fatty Acids Subcommittee, assembled by the Committee on Research on Psychiatric Treatments of the American Psychiatric Association (APA). Evidence Published literature and data presented at scientific meetings were reviewed. Specific disorders reviewed included major depressive disorder, bipolar disorder, schizophrenia, dementia, borderline personality disorder and impulsivity, and attention-deficit/hyperactivity disorder. Meta-analyses were conducted in major depressive and bipolar disorders and schizophrenia, as sufficient data were available to conduct such analyses in these areas of interest. Consensus process The subcommittee prepared the manuscript, which was reviewed and approved by the following APA committees: the Committee on Research on Psychiatric Treatments, the Council on Research, and the Joint Reference Committee. Conclusions The preponderance of epidemiologic and tissue compositional studies supports a protective effect of omega-3 EFA intake, particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), in mood disorders. Meta-analyses of randomized controlled trials demonstrate a statistically significant benefit in unipolar and bipolar depression (p = .02). The results were highly heterogene…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“they are best studied as an augmentation treatment [23-25] rather than monotherapy [26].”
From Complementary and alternative medicine therapies for perinatal depression (2014) · cites this paper as [26]
Citations
Cites
Omega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162 · cited 1×
“Medical Benefits The typical American diet is characterized by suboptimal intake of omega-3 EFA relative to omega-6 fatty acids.(10) General health benefits are associated with omega-3 EFA, such as cardiovascular benefits.”
BackgroundOmega-3 Fatty Acids in Inflammation and Autoimmune Diseases
Simopoulos, A. P. (2002) · Journal of the American College of Nutrition · doi:10.1080/07315724.2002.10719248 · Cited by 2,009 · cited 5×
“Biological Mechanisms Several biological mechanisms potentially explain the impact of omega-3 EFA in psychiatric disorders; these include (1) increased serotonergic neurotransmission,(19,20) (2) alterations in dopaminergic function,(21,22) (3) regulation of corticotropin-releasing factor,(23) (4) inhibition of protein…”
BackgroundInfluentialConsumption of Fish and n-3 Fatty Acids and Risk of Incident Alzheimer Disease
Morris, M. C., Evans, D. A., Bienias, J. L., Tangney, C. C., Bennett, D. A., Wilson, R. S., Aggarwal, N., & Schneider, J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.940 · Cited by 1,135 · cited 2×
“Morris et al.89 conducted a prospective cohort study of dietary omega-3 EFA and incident AD.”
BackgroundMechanisms of action of docosahexaenoic acid in the nervous system
Salem, N., Litman, B., Kim, H., & Gawrisch, K. (2001) · Lipids · doi:10.1007/s11745-001-0805-6 · Cited by 919 · cited 2×
“Omega-3 essential fatty acids (EFA) are of particular interest, as they are selectively concentrated in synaptic neuronal membranes and regulate vascular and immune functions that affect the central nervous system.(4) Because omega-3 EFA are available from dietary sources only, it is likely that there are psychiatric…”
BackgroundFish consumption and major depression
Hibbeln, J. R. (1998) · The Lancet · doi:10.1016/s0140-6736(05)79168-6 · Cited by 896
Self-citationDietary fat intake and the risk of incident dementia in the Rotterdam study
Kalmijn, S., Launer, L. J., Ott, A., Witteman, J. C. M., Hofman, A., & Breteler, M. M. B. (1997) · Annals of Neurology · doi:10.1002/ana.410420514 · Cited by 895
Omega 3 Fatty Acids in Bipolar Disorder: A Preliminary Double-blind, Placebo-Controlled Trial
Stoll, A. L., Severus, W. E., Freeman, M. P., Rueter, S., Zboyan, H. A., Diamond, E., Cress, K. K., & Marangell, L. B. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.5.407 · Cited by 814
Self-citationEffect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease
Belluzzi, A., Brignola, C., Campieri, M., Pera, A., Boschi, S., & Miglioli, M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606133342401 · Cited by 766
Are Mood Disorders and Obesity Related? A Review for the Mental Health Professional
McElroy, S. L., Kotwal, R., Malhotra, S., Nelson, E. B., Keck, P. E., & Nemeroff, C. B. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0507 · Cited by 652 · cited 1×
“1963 J Clin Psychiatry 67:12, December 2006 are associated with weight gain, diabetes, and cardiovascular risk factors.(132,133) Patients with psychiatric diagnoses have increased rates of tobacco smoking.”
BackgroundSelf-citationNemets, B., Stahl, Z., & Belmaker, R. H. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.477 · Cited by 627 · cited 2×
“Nemets et al.63 found significant antidepressant effects using ethyl ester EPA (2 g/day) in a placebocontrolled adjunctive study for refractory depression.”
MethodPeet, M., & Horrobin, D. F. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.10.913 · Cited by 614 · cited 1×
“This observation raises the possibility that omega-3 EFA have a “ceiling,” or maximally effective dose.(62) A”
BackgroundSelf-citationKris-Etherton, P. M., Harris, W. S., & Appel, L. J. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000057393.97337.ae · Cited by 596 · cited 1×
“General health benefits are associated with omega-3 EFA, such as cardiovascular benefits.(5) Data suggest a role of omega-3 EFA in the prevention and treatment of gastrointestinal,(11) rheumatologic,(6) bone,(12) and respiratory illnesses.”
BackgroundOmega-3 fatty acids in major depressive disorder
Su, K.-P., Huang, S.-Y., Chiu, C.-C., & Shen, W. W. (2003) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(03)00032-4 · Cited by 596 · cited 1×
“Su et al.(64) reported a significantly greater reduction in HAM-D scores with the combination of EPA plus DHA (9.”
BackgroundDepletion of Omega-3 Fatty Acid Levels in Red Blood Cell Membranes of Depressive Patients
Peet, M., Murphy, B., Shay, J., & Horrobin, D. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00206-0 · Cited by 581 · cited 2×
“Peet et al.46 found that the omega-3 EFA composition of erythrocyte membrane phospholipids was significantly lower in depressed subjects than in controls.”
BackgroundSelf-citationHibbeln, J. R. (2002) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00374-3 · Cited by 508
Self-citationWillatts, P., Forsyth, J., DiModugno, M., Varma, S., & Colvin, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11374-5 · Cited by 491 · cited 1×
“In utero exposure to higher levels of omega-3 EFA and supplementation in infant formula are associated with improved cognitive and visual performance in children.(17,18) According to the American Heart Association (AHA) Guidelines,(5) the cardiovascular benefits of omega-3 EFA include decreased risk for arrhythmias an…”
BackgroundFish, meat, and risk of dementia: cohort study
Barberger-Gateau, P. (2002) · BMJ · doi:10.1136/bmj.325.7370.932 · Cited by 486
Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration
Olsen, S. F., Dalby Sørensen, J., Secher, N. J., Hedegaard, M., Brink Henriksen, T., Hansen, H. S., & Grant, A. (1992) · The Lancet · doi:10.1016/0140-6736(92)90533-9 · Cited by 484
Edwards, R. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(97)00166-3 · Cited by 470 · cited 2×
“Edwards et al.(45) found that depressed subjects had lower erythrocyte omega-3 EFA levels compared to nondepressed controls, and depression severity correlated with lower dietary intakes of omega-3 EFA.”
BackgroundAdams, P. B., Lawson, S., Sanigorski, A., & Sinclair, A. J. (1996) · Lipids · doi:10.1007/bf02637069 · Cited by 468
Maes, M., Christophe, A., Delanghe, J., Altamura, C., Neels, H., & Meltzer, H. Y. (1999) · Psychiatry Research · doi:10.1016/s0165-1781(99)00014-1 · Cited by 453 · cited 2×
“Elderly men with depression, compared with controls, had lower adipose omega-3 EFA, a marker of long-term intake.47 Higher plasma ratios of omega-6 to omega-3 fatty acids were also reported among depressed elderly men compared to age-matched controls.48 Methodological and design problems have impaired interpretation o…”
BackgroundEssential fatty acid metabolism in boys with attention-deficit hyperactivity disorder
Stevens, L., Zentall, S., Deck, J., Abate, M., Watkins, B., Lipp, Sr., & Burgess, Jr. (1995) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.4.761 · Cited by 445
Richardson, A. J., & Montgomery, P. (2005) · Pediatrics · doi:10.1542/peds.2004-2164 · Cited by 438 · cited 1×
“In ADHD and related disorders, 2 trials of DHA alone were negative,(111,112) while 3 others using both EPA and DHA with omega-6 fatty acids yielded positive findings.(103,104,113) At this time, the preponderance of the evidence suggests that the most consistently efficacious formulation of omega-3 EFA in psychiatric d…”
BackgroundSelf-citationMaes, M., Smith, R., Christophe, A., Cosyns, P., Desnyder, R., & Meltzer, H. (1996) · Journal of Affective Disorders · doi:10.1016/0165-0327(95)00092-5 · Cited by 417
Docosahexaenoic acid promotes neurite growth in hippocampal neurons
Calderon, F., & Kim, H. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02520.x · Cited by 415
Vitamin B12, Folate, and Homocysteine in Depression: The Rotterdam Study
Tiemeier, H., van Tuijl, H. R., Hofman, A., Meijer, J., Kiliaan, A. J., & Breteler, M. M. B. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.12.2099 · Cited by 408 · cited 1×
“For example, deficiencies in niacin, thiamine, vitamin B12, and folate are known to have adverse neuropsychiatric effects.(2,3) Omega-3 essential fatty acids (EFA) are of particular interest, as they are selectively concentrated in synaptic neuronal membranes and regulate vascular and immune functions that affect the…”
BackgroundAssociation of Cystic Fibrosis with Abnormalities in Fatty Acid Metabolism
Freedman, S. D., Blanco, P. G., Zaman, M. M., Shea, J. C., Ollero, M., Hopper, I. K., Weed, D. A., Gelrud, A., Regan, M. M., Laposata, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa021218 · Cited by 395 · cited 1×
“Data suggest a role of omega-3 EFA in the prevention and treatment of gastrointestinal,(11) rheumatologic,(6) bone,(12) and respiratory illnesses.(7,13) Omega-3 EFA consumption may decrease the risk of breast,(14) prostate,(15) and lung cancer.”
BackgroundMarangell, L. B., Martinez, J. M., Zboyan, H. A., Kertz, B., Kim, H. F. S., & Puryear, L. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.5.996 · Cited by 380
Self-citationRichardson, A. J., & Puri, B. K. (2002) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(01)00254-8 · Cited by 378
Self-citationVoigt, R. G., Llorente, A. M., Jensen, C. L., Fraley, J. K., Berretta, M. C., & Heird, W. C. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116050 · Cited by 365 · cited 1×
“There are currently 2 published placebo-controlled trials of adjunctive DHA treatment in ADHD demonstrating lack of benefit.(111,112) However, combined omega-3 and omega-6 supplements (fish oil and evening primrose oil) in children with behavior and learning difficulties have shown therapeutic benefit in 3 other studi…”
BackgroundFish Consumption and Depressive Symptoms in the General Population in Finland
Tanskanen, A., Hibbeln, J. R., Tuomilehto, J., Uutela, A., Haukkala, A., Viinamäki, H., Lehtonen, J., & Vartiainen, E. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.4.529 · Cited by 360
Self-citationZanarini, M. C., & Frankenburg, F. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.1.167 · Cited by 352 · cited 4×
“Little has been reported regarding adverse psychiatric side effects except for 1 case of hypomania that occurred concomitantly with the use of omega-3 EFA supplementation.131 In that case report, a patient with major depressive disorder who was asymptomatic and not utilizing medications began a regimen of DHA 330 mg a…”
BackgroundInfluentialDietary essential fatty acids and brain function: a developmental perspective on mechanisms
Wainwright, P. E. (2002) · Proceedings of the Nutrition Society · doi:10.1079/pns2001130 · Cited by 346
EFA supplementation in children with inattention, hyperactivity, and other disruptive behaviors
Stevens, L., Zhang, W., Peck, L., Kuczek, T., Grevstad, N., Mahon, A., Zentall, S. S., Eugene Arnold, L., & Burgess, J. R. (2003) · Lipids · doi:10.1007/s11745-006-1155-0 · Cited by 337 · cited 3×
“Stevens et al.(103) randomly assigned 50 children with ADHD-type symptoms into 2 treatment groups stratified for medication and gender.”
BackgroundPeet, M., & Horrobin, D. F. (2002) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(01)00048-6 · Cited by 329
Self-citationPeet, M., Brind, J., Ramchand, C. N., Shah, S., & Vankar, G. K. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(00)00083-9 · Cited by 329 · cited 1×
“In addition, a study of patients with schizophrenia demonstrated significantly greater efficacy in symptom reduction with EPA, compared with DHA and placebo groups.(82) In ADHD and related disorders, 2 trials of DHA alone were negative,(111,112) while 3 others using both EPA and DHA with omega-6 fatty acids yielded po…”
ResultSelf-citationDiet and risk of dementia: Does fat matter?: The Rotterdam Study
Engelhart, M. J., Geerlings, M. I., Ruitenberg, A., van Swieten, J. C., Hofman, A., Witteman, J. C. M., & Breteler, M. M. B. (2002) · Neurology · doi:10.1212/01.wnl.0000038345.77753.46 · Cited by 324
Kitajka, K., Puskás, L. G., Zvara, Á., Hackler, L., Barceló-Coblijn, G., Yeo, Y. K., & Farkas, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042698699 · Cited by 323
Fenton, W. S., Dickerson, F., Boronow, J., Hibbeln, J. R., & Knable, M. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2071 · Cited by 323 · cited 1×
“In a double-blind, placebo-controlled trial of adjunctive EPA in 87 patients with schizophrenia, a 16-week trial of 3 g/day of EPA was not significantly superior to placebo.(83) In contrast, in another trial, 3 g/day of ethyl-EPA augmentation resulted in significant improvements after 12 weeks in both schizophrenia sy…”
ResultSelf-citationCross-National Comparisons of Seafood Consumption and Rates of Bipolar Disorders
Noaghiul, S., & Hibbeln, J. R. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.12.2222 · Cited by 316
Self-citationFrangou, S., Lewis, M., & McCrone, P. (2006) · British Journal of Psychiatry · doi:10.1192/bjp.188.1.46 · Cited by 309 · cited 3×
“In bipolar disorder, one positive placebo-controlled study utilized a combination of EPA and DHA,(67) and another utilized EPA alone.(68) In addition, a study of patients with schizophrenia demonstrated significantly greater efficacy in symptom reduction with EPA, compared with DHA and placebo groups.”
BackgroundMethodInfluentialKhan, M. (2002) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00334-6 · Cited by 299
Lands, W. E. M., Libelt, B., Morris, A., Kramer, N. C., Prewitt, T. E., Bowen, P., Schmeisser, D., Davidson, M. H., & Burns, J. H. (1992) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/0925-4439(92)90063-s · Cited by 289 · cited 1×
“As demonstrated by human and animal models, after chronic deficiency, the time course required for dietary supplementation to result in restoration of EFA in cerebral membranes may be longer than the usual duration of acute treatment trials in psychiatric disorders.(137,138) In the decision for clinical use of any the…”
BackgroundHirayama, S., Hamazaki, T., & Terasawa, K. (2004) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601830 · Cited by 288
Dietary intake of n−3 and n−6 fatty acids and the risk of prostate cancer
Leitzmann, M. F., Stampfer, M. J., Michaud, D. S., Augustsson, K., Colditz, G. C., Willett, W. C., & Giovannucci, E. L. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.1.204 · Cited by 287
Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus
GLAUBER, H., WALLACE, P., GRIVER, K., & BRECHTEL, G. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-5-663 · Cited by 285 · cited 1×
“However, some data suggest that supplementation potentially alters glucose metabolism in diabetics.(125,126) Hypervitaminosis A has been reported with use of high-dose fish oil supplements in 1 patient.”
BackgroundPlasma fatty acid composition and depression are associated in the elderly: the Rotterdam Study
Tiemeier, H., van Tuijl, H. R., Hofman, A., Kiliaan, A. J., & Breteler, M. M. (2003) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.40 · Cited by 285 · cited 1×
“Higher plasma ratios of omega-6 to omega-3 fatty acids were also reported among depressed elderly men compared to age-matched controls.(48) Methodological and design problems have impaired interpretation of 2 early studies in which increases in EPA and DHA in the serum and erythrocyte membranes of subjects with affect…”
ResultFish Consumption, Depression, and Suicidality in a General Population
Tanskanen, A., Hibbeln, J. R., Hintikka, J., Haatainen, K., Honkalampi, K., & Viinamäki, H. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.5.512 · Cited by 275
Self-citationIs Low Dietary Intake of Omega-3 Fatty Acids Associated With Depression?
Hakkarainen, R., Partonen, T., Haukka, J., Virtamo, J., Albanes, D., & Lönnqvist, J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.3.567 · Cited by 273
Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production
Broughton, K., Johnson, C., Pace, B., Liebman, M., & Kleppinger, K. (1997) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/65.4.1011 · Cited by 270 · cited 1×
“Data suggest a role of omega-3 EFA in the prevention and treatment of gastrointestinal,(11) rheumatologic,(6) bone,(12) and respiratory illnesses.(7,13) Omega-3 EFA consumption may decrease the risk of breast,(14) prostate,(15) and lung cancer.”
BackgroundDecline in fish consumption among pregnant women after a national mercury advisory
Oken, E. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(03)00484-8 · Cited by 262 · cited 1×
“Not surprisingly, fish consumption among pregnant women has decreased.(117) Diminishing omega-3 EFA intake among pregnant women is concerning, as Oken et al.”
BackgroundOmega-3 fatty acids in boys with behavior, learning, and health problems
Stevens, L. (1996) · Physiology & Behavior · doi:10.1016/0031-9384(95)02207-4 · Cited by 258
Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children
Mitchell, E. A., Aman, M. G., Turbott, S. H., & Manku, M. (1987) · Clinical Pediatrics · doi:10.1177/000992288702600805 · Cited by 246
Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat
Kodas, E., Galineau, L., Bodard, S., Vancassel, S., Guilloteau, D., Besnard, J., & Chalon, S. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02401.x · Cited by 244
Hibbeln, J. R., Linnoila, M., Umhau, J. C., Rawlings, R., George, D. T., & Salem, N. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00141-3 · Cited by 237
Self-citationKeck, P. E., Mintz, J., McElroy, S. L., Freeman, M. P., Suppes, T., Frye, M. A., Altshuler, L. L., Kupka, R., Nolen, W. A., Leverich, G. S., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.056 · Cited by 234 · cited 3×
“Keck et al.(69) conducted a double-blind, placebo-controlled trial of adjunctive ethyl ester EPA 6 g/day for 4 months in patients with bipolar depression (N = 59) or rapid cycling (N = 62).”
ResultInfluentialSelf-citationFish consumption and self-reported physical and mental health status
Silvers, K. M., & Scott, K. M. (2002) · Public Health Nutrition · doi:10.1079/phn2001308 · Cited by 231
Williams, C., Birch, E. E., Emmett, P. M., & Northstone, K. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.316 · Cited by 222
Frasure-Smith, N., Lespérance, F., & Julien, P. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.01.021 · Cited by 221 · cited 1×
“In addition, lower serum omega-3 EFA levels are associated with depression after acute coronary events.(52) In populations of patients with schizophrenia, levels of erythrocyte omega-3 PUFA have generally been lower than in healthy controls.”
BackgroundThe dopamine mesocorticolimbic pathway is affected by deficiency in n−3 polyunsaturated fatty acids
Zimmer, L., Vancassel, S., Cantagrel, S., Breton, P., Delamanche, S., Guilloteau, D., Durand, G., & Chalon, S. (2002) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/75.4.662 · Cited by 218
Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression
Silvers, K. M., Woolley, C. C., Hamilton, F. C., Watts, P. M., & Watson, R. A. (2005) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2004.11.004 · Cited by 207 · cited 2×
“Silvers et al.(65) conducted a randomized, double-blind trial of fish oil (8 g/day of fish oil that provided 0.”
BackgroundInfluentialω-3 Fatty acids: Comparison of plant and seafood sources in human nutrition
Nettleton, J. A. (1991) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(21)01118-4 · Cited by 207 · cited 2×
“In addition to seafood consumption, tissue composition is mediated by the dietary intake of the precursors α-linolenic acid (18:3n-3), which can be converted to EPA and DHA, and linoleic acid (18:2n-6), which can be converted to AA.(9) Plant sources rich in α-linolenic acid include mungo bean, flaxseed, and canola oil.”
BackgroundDeficiency of essential fatty acids and membrane fluidity during pregnancy and lactation.
Holman, R. T., Johnson, S. B., & Ogburn, P. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.4835 · Cited by 205 · cited 1×
“Perinatal Depression Adequate maternal intake of omega-3 EFA is necessary for optimal in utero brain and nervous system development, and DHA is selectively transferred to the developing fetus during pregnancy.(70,71) Omega-3 EFA stores decrease progressively during normal pregnancy.”
BackgroundLlorente, A. M., Jensen, C. L., Voigt, R. G., Fraley, J. K., Berretta, M. C., & Heird, W. C. (2003) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2003.275 · Cited by 189 · cited 1×
“In a post hoc analysis of 138 healthy breastfeeding mothers who were supplemented with DHA 200 mg/day or placebo during the 4 months after childbirth, no differences in depression scores were detected between the groups.(80)”
MethodReversal of docosahexaenoic acid deficiency in the rat brain, retina, liver, and serum
Moriguchi, T., Loewke, J., Garrison, M., Catalan, J. N., & Salem, N. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31666-7 · Cited by 185
Lindeman, S., Hämäläinen, J., Isometsä, E., Kaprio, J., Poikolainen, K., Heikkinen, M., & Aro, H. (2000) · Acta Psychiatrica Scandinavica · doi:10.1034/j.1600-0447.2000.102003178.x · Cited by 183
Otto, S., Houwelingen, A., Antal, M., Manninen, A., Godfrey, K., López-Jaramillo, P., & Hornstra, G. (1997) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1600390 · Cited by 177 · cited 1×
“Omega-3 EFA stores decrease progressively during normal pregnancy.(72) Intake of omega-3 EFA by pregnant and lactating women in the United States reaches only 20% to 60% of recommended intake.”
BackgroundBiological Aspects of the Link between Smoking and Depression
Quattrocki, E., Baird, A., & Yurgelun-Todd, D. (2000) · Harvard Review of Psychiatry · doi:10.1080/hrp_8.3.99 · Cited by 176 · cited 1×
“In patients with psychotic disorders, smoking is associated with lower dietary intake of omega-3 EFA and lower erythrocyte DHA content.(59) Thus, a greater severity of psychiatric symptoms may influence diets, smoking, and self-care, but poor nutrition also may contribute to worsening of symptoms.”
BackgroundPeet, M., Laugharne, J. D. E., Mellor, J., & Ramchand, C. N. (1996) · Prostaglandins, Leukotrienes and Essential Fatty Acids · doi:10.1016/s0952-3278(96)90148-9 · Cited by 170
Self-citationProtein Kinase Inhibition by ω-3 Fatty Acids
Mirnikjoo, B., Brown, S. E., Kim, H. F. S., Marangell, L. B., Sweatt, J. D., & Weeber, E. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008150200 · Cited by 166
Self-citationCan nutrient supplements modify brain function?
Fernstrom, J. D. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/71.6.1669s · Cited by 165 · cited 1×
“J Clin Psychiatry 67:12, December 2006 states is not novel.(1) For example, deficiencies in niacin, thiamine, vitamin B12, and folate are known to have adverse neuropsychiatric effects.”
BackgroundOmega-3 Fatty Acids in Adipose Tissue and Risk of Myocardial Infarction: The EURAMIC Study
Guallar, E., Aro, A., Jiménez, F. J., Martín-Moreno, J. M., Salminen, I., van’t Veer, P., Kardinaal, A. F. M., Gómez-Aracena, J., Martin, B. C., Kohlmeier, L., et al. (1999) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.19.4.1111 · Cited by 152 · cited 1×
“In humans, levels of omega-3 EFA in adipose tissue reflect dietary intake periods of up to 2 or 3 years.(42) Several groups have demonstrated that patients with major depressive disorder exhibit lower levels of omega-3 EFA than controls.”
BackgroundSmoking cessation approaches for persons with mental illness or addictive disorders
el-Guebaly, N., Cathcart, J., Currie, S., Brown, D., & Gloster, S. (2002) · Psychiatric Services · doi:10.1176/appi.ps.53.9.1166 · Cited by 151 · cited 1×
“Patients with psychiatric diagnoses have increased rates of tobacco smoking.(134) Therefore, interventions that take into account the overall health of patients are imperative.”
BackgroundFat consumption and schizophrenia
Christensen, O., & Christensen, E. (1988) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1988.tb06388.x · Cited by 147 · cited 1×
“Although in one study the prevalence of schizophrenia was not associated with seafood consumption,(34) a poorer course of illness has been reported for persons who live in countries with diets containing a high ratio of saturated to polyunsaturated fats.(40) In summary, cross-national and country-specific epidemiologi…”
BackgroundSchmidt, E. B., & Dyerberg, J. (1994) · Drugs · doi:10.2165/00003495-199447030-00003 · Cited by 146
Omega-3 fatty acids and risk of cognitive impairment and dementia
Laurin, D., Verreault, R., Lindsay, J., Dewailly, É., & Holub, B. J. (2003) · Journal of Alzheimer's Disease · doi:10.3233/jad-2003-5407 · Cited by 145 · cited 1×
“Casecontrol studies have also been inconsistent with regards to associations between omega-3 EFA and AD risk.(93,94)”
ResultBekaroǧlu, M., Asian, Y., Gedik, Y., Deǧer, O., Mocan, H., Erduran, E., & Karahan, C. (1996) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1996.tb01395.x · Cited by 142 · cited 1×
“There are currently 2 published placebo-controlled trials of adjunctive DHA treatment in ADHD demonstrating lack of benefit.(111,112) However, combined omega-3 and omega-6 supplements (fish oil and evening primrose oil) in children with behavior and learning difficulties have shown therapeutic benefit in 3 other studi…”
BackgroundCorrigan, F. M., Horrobin, D. F., SKINNER, E. R., BESSON, J. A. O., & Cooper, M. B. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(97)00125-8 · Cited by 140 · cited 1×
“Postmortem brain assessments show lower omega-3 EFA content in the parahippocampal cortex in subjects with Alzheimer’s disease (AD) compared to controls.(88) Epidemiologic studies have yielded inconsistent findings about omega-3 EFA intake and risk of dementia.”
BackgroundHibbeln, J. R., Makino, K. K., Martin, C. E., Dickerson, F., Boronow, J. J., & Fenton, W. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01549-4 · Cited by 136 · cited 1×
“However, some findings may have been confounded by effects of medication, diet, smoking, and storage artifact.(57,58) Studies of unmedicated patients with schizophrenia have shown both reduced(55,56) and elevated(58) levels of DHA in erythrocytes.”
BackgroundSelf-citationIribarren, C., Markovitz, J. H., Jacobs, D. R., Schreiner, P. J., Daviglus, M. L., & Hibbeln, J. R. (2003) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601739 · Cited by 127
Self-citationLow HDL cholesterol, aggression and altered central serotonergic activity
Buydens‐Branchey, L., Branchey, M. H., Hudson, J., & Fergeson, P. (2000) · Psychiatry Research · doi:10.1016/s0165-1781(99)00126-2 · Cited by 125
Weidner, G., Connor, S. L., Hollis, J. F., & Connor, W. E. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-10-820 · Cited by 125
Zimmer, L., Hembert, S., Durand, G., Breton, P., Guilloteau, D., Besnard, J., & Chalon, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00938-5 · Cited by 124
Fish Oil Interaction with Warfarin
Buckley, M. S., Goff, A. D., & Knapp, W. E. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d007 · Cited by 123 · cited 1×
“However, 1 patient treated with warfarin experienced clinically significant changes in coagulation after the dose of concomitant fish oil was changed from 1000 to 2000 mg/day.(130) Clinicians need to be aware of potential drug interactions between omega-3 EFA supplements and anticoagulant medications.”
BackgroundLipids, Membrane Receptors, and Enzymes: Effects of Dietary Fatty Acids
Kinsella, J. E. (1990) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719001400511 · Cited by 121
Rogers, I., Emmett, P., Ness, A., & Golding, J. (2004) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2003.013565 · Cited by 120 · cited 1×
“Inadequate intake increases the risk of intrauterine growth retardation and visual problems among children.(74,75) Olsen et al.”
BackgroundBreast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
Ambrosone, C. B., Freudenheim, J. L., Sinha, R., Graham, S., Marshall, J. R., Vena, J. E., Laughlin, R., Nemoto, T., & Shields, P. G. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980316)75:6<825::aid-ijc2>3.0.co;2-x · Cited by 117
Clinical trials of fatty acid treatment in ADHD, dyslexia, dyspraxia and the autistic spectrum
Richardson, A. J. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.12.020 · Cited by 116 · cited 1×
“Equally important is the duration of the therapy.(136) As demonstrated by human and animal models, after chronic deficiency, the time course required for dietary supplementation to result in restoration of EFA in cerebral membranes may be longer than the usual duration of acute treatment trials in psychiatric disorder…”
BackgroundSelf-citationForan, S. E., Flood, J. G., & Lewandrowski, K. B. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1603-momlic · Cited by 112
Eritsland, J., Arnesen, H., Seljeflot, I., & Kierulf, P. (1995) · Blood Coagulation & Fibrinolysis · doi:10.1097/00001721-199502000-00003 · Cited by 107 · cited 1×
“4 g/day EPA and DHA) or placebo did not affect bleeding time or other parameters of coagulation or fibrinolysis among subjects who underwent coronary artery bypass surgery.(128) All subjects also received anticoagulation therapy with warfarin or aspirin and were followed for 9 months postoperatively.”
BackgroundEicosapentaenoic acid inhibits bone loss due to ovariectomy in rats
Sakaguchi, K., Morita, I., & Murota, S. (1994) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(94)90151-1 · Cited by 107
de Wilde, M. C., Farkas, E., Gerrits, M., Kiliaan, A. J., & Luiten, P. G. M. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02695-1 · Cited by 101 · cited 1×
“Dementia In animal studies, omega-3 EFA intake improves cerebral perfusion and cognitive performance.(87) Postmortem brain assessments show lower omega-3 EFA content in the parahippocampal cortex in subjects with Alzheimer’s disease (AD) compared to controls.”
BackgroundTsukada, H., Kakiuchi, T., Fukumoto, D., Nishiyama, S., & Koga, K. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02115-6 · Cited by 95
Marangell, L. B., Martinez, J. M., Zboyan, H. A., Chong., H., & Puryear, L. J. (2004) · Depression and Anxiety · doi:10.1002/da.10148 · Cited by 92 · cited 2×
“In a small open trial (N = 7), EPA and DHA supplementation that began in the third trimester did not prevent the occurrence of PPD in women with histories of PPD.79 In a post hoc analysis of 138 healthy breastfeeding mothers who were supplemented with DHA 200 mg/day or placebo during the 4 months after childbirth, no…”
BackgroundSelf-citationRudin, D. O. (1981) · PubMed · Cited by 92
Omega-3 fatty acid ethyl esters increase heart rate variability in patients with coronary disease
Villa, B., Calabresi, L., Chiesa, G., Risé, P., Galli, C., & Sirtori, C. R. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0989 · Cited by 88
Fish oil in people with type 2 diabetes mellitus
Farmer, A., Montori, V, Dinneen, S., & Clar, C. (2001) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003205 · Cited by 82 · cited 1×
“Side Effects The preponderance of the literature supports the safety of omega-3 EFA in diabetes.(124) However, some data suggest that supplementation potentially alters glucose metabolism in diabetics.”
BackgroundVirkkunen, M. E., Horrobin, D. F., Jenkins, D. K., & Manku, M. S. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90051-5 · Cited by 82
Dietary fat intake and risk of lung cancer: a prospective study of 51,452 Norwegian men and women
Veierød, M. B., Laake, P., & Thelle, D. S. (1997) · European Journal of Cancer Prevention · doi:10.1097/00008469-199712000-00009 · Cited by 77 · cited 1×
“Omega-3 EFA consumption may decrease the risk of breast,(14) prostate,(15) and lung cancer.(16) In utero exposure to higher levels of omega-3 EFA and supplementation in infant formula are associated with improved cognitive and visual performance in children.”
BackgroundSeafood Consumption and Homicide Mortality
Hibbeln, J. R. (2000) · KARGER eBooks · doi:10.1159/000059747 · Cited by 76
Self-citationReduction of organochlorine contaminants from fish oil during refining
Hilbert, G., Lillemark, L., Balchen, S., & Højskov, C. S. (1998) · Chemosphere · doi:10.1016/s0045-6535(98)00122-2 · Cited by 72 · cited 1×
“Fish oil capsules are refined to reduce contaminants, including mercury and polychlorinated biphenyls (PCBs), to negligible levels.(122) As analyzed and published by Consumer Reports in July 2003, 16 brands of fish oil were tested and found to contain nondetectable quantities of mercury, PCBs, and dioxin.”
BackgroundThe Omega-3 Story: Nutritional Prevention of Preterm Birth and Other Adverse Pregnancy Outcomes
McGregor, J. A., D. Allen, K. G., Harris, M. A., Reece, M., Wheeler, M., French, J. I., & Morrison, J. (2001) · Obstetric and Gynecologic Survey · doi:10.1097/00006254-200105001-00001 · Cited by 67 · cited 1×
“Environmental Contaminants Omega-3 EFA are required for optimal development in utero and during infancy, a literature that has been reviewed in detail elsewhere.(115) Pregnant and breastfeeding women need adequate omega-3 EFA intake to meet the needs of the baby in utero and during infancy, as well as their own dietar…”
BackgroundVESSBY, B., & BOBERG, M. (1990) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1990.tb00211.x · Cited by 64 · cited 1×
“However, some data suggest that supplementation potentially alters glucose metabolism in diabetics.(125,126) Hypervitaminosis A has been reported with use of high-dose fish oil supplements in 1 patient.”
BackgroundHibbeln, J. R., Bissette, G., Umhau, J. C., & George, D. T. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.08.021 · Cited by 60
Self-citationPolyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients
Peet, M., Shah, S., Selvam, K., & Ramchand, C. N. (2004) · The World Journal of Biological Psychiatry · doi:10.1080/15622970410029917 · Cited by 59 · cited 1×
“However, some findings may have been confounded by effects of medication, diet, smoking, and storage artifact.(57,58) Studies of unmedicated patients with schizophrenia have shown both reduced(55,56) and elevated(58) levels of DHA in erythrocytes.”
BackgroundSelf-citationLong chain polyunsaturated fatty acids in endogenous depression.
Ellis, F. R., & Sanders, T. A. (1977) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.40.2.168 · Cited by 57 · cited 1×
“Methodological and design problems have impaired interpretation of 2 early studies in which increases in EPA and DHA in the serum and erythrocyte membranes of subjects with affective disorders were reported.(49,50) Maes et al.”
BackgroundWang, J. M., Chertov, O., Proost, P., Li, J. J., Menton, P., Xu, L., Sozzani, S., Mantovani, A., Gong, W., Schirrmacher, V., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980316)75:6<925::aid-ijc16>3.0.co;2-1 · Cited by 56
Hamazaki, T., Itomura, M., Sawazaki, S., & Nagao, Y. (2000) · BioFactors · doi:10.1002/biof.5520130108 · Cited by 53
Hypomania Associated With ω3 Fatty Acids
Kinrys, G. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.7.715-a · Cited by 52 · cited 1×
“Little has been reported regarding adverse psychiatric side effects except for 1 case of hypomania that occurred concomitantly with the use of omega-3 EFA supplementation.(131) In that case report, a patient with major depressive disorder who was asymptomatic and not utilizing medications began a regimen of DHA 330 mg…”
BackgroundPlasma and erythrocyte membrane long chain polyunsaturated fatty acids in endogenous depression
FEHILY, A. M., Bowey, O. A. M., Ellis, F. R., Meade, B. W., & Dickerson, J. W. T. (1981) · Neurochemistry International · doi:10.1016/0197-0186(81)90047-4 · Cited by 50 · cited 1×
“Methodological and design problems have impaired interpretation of 2 early studies in which increases in EPA and DHA in the serum and erythrocyte membranes of subjects with affective disorders were reported.(49,50) Maes et al.”
BackgroundMamalakis, G., Kiriakakis, M., Tsibinos, G., & Kafatos, A. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.10.005 · Cited by 49 · cited 1×
“Elderly men with depression, compared with controls, had lower adipose omega-3 EFA, a marker of long-term intake.(47) Higher plasma ratios of omega-6 to omega-3 fatty acids were also reported among depressed elderly men compared to age-matched controls.”
ResultAn open trial of Omega-3 fatty acids for depression in pregnancy
Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Watchman, M., & Gelenberg, A. J. (2006) · Acta Neuropsychiatrica · doi:10.1111/j.0924-2708.2006.00113.x · Cited by 49 · cited 1×
“In one open-label, flexible-dose trial, the efficacy of a combination of EPA and DHA was assessed for the treatment of depression during pregnancy in 15 subjects.(77) With a mean final dose of 1.”
MethodSelf-citationMueller, B. A., Talbert, R. L., Tegeler, C. H., & Prihoda, T. J. (1991) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1991.tb03706.x · Cited by 44 · cited 2×
“Mueller et al.(129) found that aspirin did not significantly increase bleeding time after high-dose omega-3 EFA supplementation.”
BackgroundEffects of docosapentaenoic acid on neuronal apoptosis
Kim, H., Akbar, M., & Lau, A. (2003) · Lipids · doi:10.1007/s11745-003-1083-z · Cited by 41
Leng, G. C., Smith, F. B., Fowkes, F. G. R., Horrobin, D. F., Ells, K., Morse-Fisher, N., & Lowe, G. D. O. (1994) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(94)90085-x · Cited by 39 · cited 1×
“Smoking is more frequent among persons with psychiatric disorders,(59,60) and levels of omega-3 EFA are lower in smokers than nonsmokers.(61) In patients with psychotic disorders, smoking is associated with lower dietary intake of omega-3 EFA and lower erythrocyte DHA content.”
BackgroundDiet during pregnancy and the risk of cerebral palsy
Petridou, E., Koussouri, M., Toupadaki, N., Youroukos, S., Papavassiliou, A., Pantelakis, S., Olsen, J., & Trichopoulos, D. (1998) · British Journal of Nutrition · doi:10.1079/bjn19980069 · Cited by 32 · cited 1×
“Dietary data support that adequate intake of omega-3 EFA during pregnancy is associated with a decreased risk of negative outcomes, including prematurity, preeclampsia, and cerebral palsy.(18,119,120) In a large placebo-controlled trial, Olsen et al.”
BackgroundPregnancy Reduces Arachidonic and Docosahexaenoic in Plasma Triacylglycerols of Korean Women
Min, Ghebremeskel, Crawford, Nam, J.-H., Kim, A., Koo, J.-N., & Suzuki, H. (2000) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831.70.2.70 · Cited by 25 · cited 1×
“Perinatal Depression Adequate maternal intake of omega-3 EFA is necessary for optimal in utero brain and nervous system development, and DHA is selectively transferred to the developing fetus during pregnancy.(70,71) Omega-3 EFA stores decrease progressively during normal pregnancy.”
BackgroundDietary intake of polyunsaturated fatty acids by pregnant or lactating women in the United States
Benisek, D. C. (2000) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(00)00762-6 · Cited by 22 · cited 2×
“Intake of omega-3 EFA by pregnant and lactating women in the United States reaches only 20% to 60% of recommended intake.(73) Inadequate intake increases the risk of intrauterine growth retardation and visual problems among children.”
BackgroundMethodAraya, J., Rojas, M. M., Fernández, P., & Mateluna, A. (1998) · PubMed · Cited by 15
Cited by
(2009) · Cited by 2,013
Brain foods: The effects of nutrients on brain function.
Gómez-Pinilla, F. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2421 · Cited by 1,372
PRACTICE GUIDELINE FOR THE Treatment of Patients With Major Depressive Disorder
Gelenberg, A. J., Freeman, P. B., Markowitz, J. C., Rosenbaum, J. F., Thase, M. E., Trivedi, M. H., & Rhoads, R. S. (2010) · Cited by 1,510
Davydov, D. M., Stewart, R., Ritchie, K., & Chaudieu, I. (2010) · Clinical Psychology Review · doi:10.1016/j.cpr.2010.03.003 · Cited by 1,189
Health Implications of High Dietary Omega-6 Polyunsaturated Fatty Acids
Patterson, E., Wall, R., Fitzgerald, G. F., Ross, R. P., & Stanton, C. (2012) · Journal of Nutrition and Metabolism · doi:10.1155/2012/539426 · Cited by 883
“the brain of AD patients [153].”
Metadata
- Authors
- Freeman, M. P., Hibbeln, J. R., Wisner, K. L., Davis, J. M., Mischoulon, D., Peet, M., Keck, P. E., Marangell, L. B., Richardson, A. J., Lake, J., & Stoll, A. L.
- Affiliations
- University of Arizona (US)
- National Institutes of Health (US)
- University of Pittsburgh (US)
- University of Maryland, Baltimore (US)
- Harvard University (US)
- University of Sheffield (GB)
- University of Cincinnati (US)
- United States Department of Veterans Affairs (US)
- Stanford University (US)
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2006-12-15
- Volume
- 67
- Issue
- 12
- Pages
- 1954-1967
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W1979122474
- Cited by
- 709
- References
- 118
- Citations by year
- 2026: 7 · 2025: 10 · 2024: 14 · 2023: 13 · 2022: 17 · 2021: 16 · 2020: 21 · 2019: 22 · 2018: 25 · 2017: 30 · 2016: 40 · 2015: 47 · 2014: 48 · 2013: 54 · 2012: 51
- FWCI
- 47.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k23at001129-05)
- National Institute of Mental Health (K23MH066265)
- National Center for Complementary and Integrative Health (5K23AT001129-05)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, major depressive disorder, bipolar disorder, schizophrenia, borderline personality disorder, attention deficit hyperactivity disorder, dementia, mood disorders, dietary supplementation, evidence-based treatment recommendations
- MeSH terms
- Mental Disorders, Humans, Tissue Distribution, Fatty Acids, Omega-3, Epidemiologic Studies
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.